TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province 610072, PR China.
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, PR China.
Phytomedicine. 2024 Jun;128:155451. doi: 10.1016/j.phymed.2024.155451. Epub 2024 Feb 12.
Phytochemicals are natural compounds derived from plants, and are now at the forefront of anti-cancer research. Macrophage immunotherapy plays a crucial role in the treatment of colorectal cancer (CRC). In the context of colorectal cancer, which remains highly prevalent and difficult to treat, it is of research value to explore the potential mechanisms and efficacy of phytochemicals targeting macrophages for CRC treatment.
The aim of this study was to gain insight into the role of phytochemical-macrophage interactions in regulating CRC and to provide a theoretical basis for the development of new therapeutic strategies in the future.
This review discusses the potential immune mechanisms of phytochemicals for the treatment of CRC by summarizing research of phytochemicals targeting macrophages.
We reviewed the PubMed, EMBASE, Web of Science and CNKI databases from their initial establishment to July 2023 to classify and summaries phytochemicals according to their mechanism of action in targeting macrophages.
The results of the literature review suggest that phytochemicals interfere with CRC development by affecting macrophages through four main mechanisms. Firstly, they modulate the production of cytotoxic substances, such as NO and ROS, by macrophages to exert anticancer effects. Secondly, phytochemicals polarize macrophages towards the M1 phenotype, inhibit M2 polarisation and enhance the anti-tumour immune responses. Thirdly, they enhance the secretion of macrophage-derived cytokines and alter the tumour microenvironment, thereby inhibiting tumor growth. Finally, they activate the immune response by targeting macrophages, triggering the recruitment of other immune cells, thereby enhancing the immune killing effect and exerting anti-tumor effects. These findings highlight phytochemicals as potential therapeutic strategies to intervene in colorectal cancer development by modulating macrophage activity, providing a strong theoretical basis for future clinical applications.
Phytochemicals exhibit potential anti-tumour effects by modulating macrophage activity and intervening in the colorectal cancer microenvironment by multiple mechanisms.
植物化学物质是从植物中提取的天然化合物,目前处于抗癌研究的前沿。巨噬细胞免疫疗法在结直肠癌(CRC)的治疗中起着至关重要的作用。在结直肠癌仍然高度流行且难以治疗的情况下,探索针对巨噬细胞的植物化学物质治疗 CRC 的潜在机制和疗效具有研究价值。
本研究旨在深入了解植物化学物质与巨噬细胞相互作用在调节 CRC 中的作用,并为未来开发新的治疗策略提供理论依据。
本综述通过总结针对巨噬细胞的植物化学物质研究,讨论了植物化学物质治疗 CRC 的潜在免疫机制。
我们检索了 PubMed、EMBASE、Web of Science 和中国知网(CNKI)数据库,从建库到 2023 年 7 月,根据作用机制对植物化学物质进行分类和总结。
文献综述的结果表明,植物化学物质通过以下四种主要机制影响巨噬细胞,从而干扰 CRC 的发展。首先,它们通过调节巨噬细胞产生的细胞毒性物质(如 NO 和 ROS)来发挥抗癌作用。其次,植物化学物质将巨噬细胞极化为 M1 表型,抑制 M2 极化并增强抗肿瘤免疫反应。第三,它们增强巨噬细胞衍生细胞因子的分泌并改变肿瘤微环境,从而抑制肿瘤生长。最后,它们通过靶向巨噬细胞激活免疫反应,触发其他免疫细胞的募集,从而增强免疫杀伤效应并发挥抗肿瘤作用。这些发现强调了植物化学物质作为通过调节巨噬细胞活性来干预结直肠癌发展的潜在治疗策略的潜力,为未来的临床应用提供了强有力的理论基础。
植物化学物质通过多种机制调节巨噬细胞活性并干预结直肠癌微环境,表现出潜在的抗肿瘤作用。